🇺🇸 FDA
Patent

US 8058025

Methods for determining efficacy of chemotherapeutic agents

granted A61PA61P17/02A61P31/00

Quick answer

US patent 8058025 (Methods for determining efficacy of chemotherapeutic agents) held by Precision Therapeutics, Inc. expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision Therapeutics, Inc.
Grant date
Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P17/02, A61P31/00, A61P35/00, A61P37/02